美国Vermillion  
Vermillion, Inc（NASDQ：VRML）成立於1993年,总部位於美国加州是一家致力于开发和发展新型高价值诊断测试并将其进行商业化推广的公司。其新型高价值诊断测试可以有助于病人的物理诊断，治疗和改进治疗结果。Vermillion连同其在业界享有盛誉的科学合作者共同致力于肿瘤，血液病，心血管已经妇女健康方面的诊断方案研究。

Vermillion, Inc. (NASDAQ: VRML) is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has diagnostic programs in oncology, hematology, cardiology and women's health.